Vectura Likes Risk Proposition Of New U.S. Partnership For Generic Lung Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
British biotech partners with unnamed multinational pharma to develop VR315, thought by many to be a generic version of GSK's Advair, in the U.S.